Page last updated: 2024-08-21

3-hydroxyflavone and Carcinoma, Renal Cell

3-hydroxyflavone has been researched along with Carcinoma, Renal Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, HR; Chiou, HL; Hsieh, MH; Hsieh, YH; Lin, CL; Tsai, JP; Yang, SF	1

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Carcinoma, Renal Cell

Article	Year
Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9. Cells, 2019, 08-21, Volume: 8, Issue:9 Topics: ADAM Proteins; Antineoplastic Agents; Carcinoma, Renal Cell; Cathepsins; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Proteins; Molecular Structure; Neoplasm Metastasis; Structure-Activity Relationship; Tumor Cells, Cultured	2019

Article

Year

Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.

Cells, 2019, 08-21, Volume: 8, Issue:9

Topics: ADAM Proteins; Antineoplastic Agents; Carcinoma, Renal Cell; Cathepsins; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Proteins; Molecular Structure; Neoplasm Metastasis; Structure-Activity Relationship; Tumor Cells, Cultured

2019